A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome

Clinical trial NCT06304103 · RECRUITING

Trial details

NCT number: NCT06304103
Sponsor: Kind Pharmaceuticals LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2025-03-14
Primary completion: 2026-12-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.